跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Stugeron Forte - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Stugeron Forte
Approved
STANDARD
Stugeron Forte
Janssen Korea ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d3e4937787cd822e
Company
Janssen Korea ltd.
Type
Standard
Approval Details
Approval Id
d3e4937787cd822e
Drug Approval Philippines Name
Stugeron Forte
Product Name
Stugeron Forte
Registration Number
DR-XY40786
Brand Name
Stugeron Forte
Generic Name
Cinnarizine
Dosage Form
Capsule
Dosage Strength
75 mg
Manufacturer
Janssen Korea ltd.
Importer
Johnson & Johnson (Philippines), Inc.
Distributor
ZUELLIG PHARMA CORPORATION
Company Detail Path
/organization/janssen-korea-ltd
Issuance Date
19 April 2022
Expiry Date
26 March 2027
Pharmacologic Category
Anti-vertigo preparations
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d3e4937787cd822e
Type
Standard
Back to Philippines FDA Approvals